These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12113682)

  • 21. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM; Chudy M; Volkers P; Löwer J
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First case of hepatitis C virus transmission by a red blood cell concentrate after introduction of nucleic acid amplification technique screening in Germany: a comparative study with various assays.
    Kretzschmar E; Chudy M; Nübling CM; Ross RS; Kruse F; Trobisch H
    Vox Sang; 2007 May; 92(4):297-301. PubMed ID: 17456153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of the results of NEQAS international external quality assessment programme for hepatitis B and C virus nucleic acid tests].
    Sayan M; Willke A; Meriç M; Etiler N
    Mikrobiyol Bul; 2009 Jan; 43(1):103-14. PubMed ID: 19334386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation on the use of detection of hepatitis C core antigen for screening blood donor].
    Wang FC; Shi ZY; Cai J; Su J
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):389-90. PubMed ID: 18322613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey.
    Sakarya S; Oncu S; Ozturk B; Oncu S
    Saudi Med J; 2004 Aug; 25(8):1070-2. PubMed ID: 15322600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [HCV RNA testing for early diagnosis of hepatitis C in blood donors--new challenge for transfusion medicine and hepatology].
    Brojer E; Letowska M; Gronowska A; Kubicka-Russel D; Liszewski G; Grabarczyk P; Medyńska J; Mikulska K; Sabliński J
    Pol Merkur Lekarski; 2004 Oct; 17(100):321-5. PubMed ID: 15690692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assays for viral sequences and their value in validation of viral elimination.
    Saldanha J
    Dev Biol Stand; 1993; 81():231-6. PubMed ID: 8174807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High prevalence of HGV coinfection with HBV or HCV among northeastern Thai blood donors.
    Barusruk S; Urwijitaroon Y
    Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):289-93. PubMed ID: 17124988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serological and molecular markers of HCV infection in Polish blood donors].
    Brojer E
    Przegl Epidemiol; 2005; 59(2):511-7. PubMed ID: 16190561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of HCV infection for post-transfusion hepatitis].
    Roggendorf M
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():12-8. PubMed ID: 8000249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elimination of false-negative hepatitis C virus RNA results by removal of inhibitors in cadaver-organ donor blood specimens.
    Padley DJ; Lucas SB; Saldanha J
    Transplantation; 2003 Jul; 76(2):432-4. PubMed ID: 12883207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of transcription mediated amplification (TMA) and reverse transcription polymerase chain reaction (RT-PCR) for detection of hepatitis C virus RNA in liver tissue.
    Hofmann WP; Dries V; Herrmann E; Gärtner B; Zeuzem S; Sarrazin C
    J Clin Virol; 2005 Apr; 32(4):289-93. PubMed ID: 15780807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Low positive anti-HCV microparticle enzyme immunoassay results: do they predict hepatitis C virus infection?].
    Sayan M; Meriç M; Mutlu B; Celebi S; Willke A
    Mikrobiyol Bul; 2006; 40(1-2):81-4. PubMed ID: 16775961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
    Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
    Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The present state and problems of HCV blood screening system in blood products].
    Yatsuhashi H; Yano M
    Nihon Rinsho; 2001 Jul; 59(7):1303-7. PubMed ID: 11494542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Status of NAT screening for HCV, HIV and HBV: experience in Japan.
    Tomono T; Murokawa H; Minegishi K; Yamanaka R; Lizuka HY; Miyamoto M; Satoh S; Nakahira S; Murozuka T; Emura H; Doi Y; Mine H; Yokoyama S; Ohnuma H; Tanaka T; Yoshikawa A; Nishioka K;
    Dev Biol (Basel); 2002; 108():29-39. PubMed ID: 12220140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.